Is oxidized low-density lipoprotein present in vivo?

Area of Science:

• Biochemistry
• Cardiovascular Medicine
• Immunology

Background:

• Oxidation of low-density lipoprotein (LDL) is a key factor in atherosclerosis pathogenesis.
• Mechanisms for in vivo LDL oxidation are well-established.
• Clinical studies suggest a link between oxidized LDL and atherosclerotic vascular disease progression.

Purpose of the Study:

• To review recent findings on the presence of oxidized LDL (ox-LDL) in vivo.
• To evaluate the significance of ox-LDL autoantibody measurements for predicting cardiovascular diseases.

Main Methods:

• Literature review of basic research, clinical, and epidemiological studies.
• Analysis of mechanisms leading to LDL oxidation.
• Assessment of autoantibody levels as biomarkers.

Main Results:

• Oxidized LDL is present in vivo and implicated in atherosclerosis.
• Serum autoantibody levels against ox-LDL show potential as predictive markers.
• The predictive value is explored across diverse patient populations.

Conclusions:

• Oxidized LDL plays a significant role in the development of atherosclerosis.
• Autoantibody measurements against ox-LDL represent a promising tool for cardiovascular disease risk assessment.
• Further research is warranted to validate ox-LDL autoantibodies as clinical predictors.